Quick Answer
CASTLE BIOSCIENCES INC reported Stockholders Equity of $470.87 million for the year ending 2025.
- CASTLE BIOSCIENCES INC showed an increase of +3.3% in Stockholders Equity from 2024 to 2025.
- This data is from CASTLE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$53.93 million | Q2 2018: -$57.05 million | Q3 2018: -$60.45 million | Q1 2019: -$49.43 million | Q2 2019: -$50.20 million | Q3 2019: $82.34 million | Q1 2020: $87.93 million | Q2 2020: $157.62 million | Q3 2020: $166.56 million | Q1 2021: $418.61 million | Q2 2021: $415.94 million | Q3 2021: $411.73 million | Q1 2022: $397.34 million | Q2 2022: $421.66 million | Q3 2022: $411.43 million | Q1 2023: $385.15 million | Q2 2023: $378.77 million | Q3 2023: $385.78 million | Q1 2024: $402.46 million | Q2 2024: $423.89 million | Q3 2024: $441.06 million | Q1 2025: $440.31 million | Q2 2025: $455.38 million | Q3 2025: $467.05 million.
- Over the full 9 years of available data (2017 to 2025), CASTLE BIOSCIENCES INC's Stockholders Equity has grown by 1,035.9%.
- Historical annual values: Fiscal year 2025: $470.87 million | Fiscal year 2024: $455.84 million | Fiscal year 2023: $391.27 million | Fiscal year 2022: $399.15 million | Fiscal year 2021: $411.74 million | Fiscal year 2020: $415.69 million | Fiscal year 2019: $85.11 million | Fiscal year 2018: -$56.57 million | Fiscal year 2017: -$50.31 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: